Monthly or Quarterly Fremanezumab Effective Against Episodic MigraineSeptember 18, 2024Headache & Migraine
Eicosapentaenoic Acid Is an Effective Adjunct Therapy for Chronic MigraineSeptember 18, 2024Headache & Migraine
Long-term Safety of Intranasal Zavegepant for Acute Treatment of MigraineSeptember 18, 2024Headache & Migraine
Migraine and GDM Raise Risk for Major Cerebro- and Cardiovascular Events in WomenSeptember 18, 2024Headache & Migraine
Meta-Analysis Shows Increased Neck Pain and Disability in MigraineSeptember 18, 2024Headache & Migraine
Ubrogepant Effectively Treats Migraine When Administered During ProdromeSeptember 18, 2024Headache & Migraine
Humanized Monoclonal Antibody Reduces Migraine Frequency in Phase 2 StudySeptember 18, 2024Headache & Migraine
Hypertension Responsible for Detrimental Effects of Leisure Screen Time on MigraineAugust 15, 2024Headache & Migraine
Atogepant Is Effective and Well Tolerated for Migraine Prevention, Irrespective of DoseAugust 15, 2024Headache & Migraine
Anti-CGRP Antibody Efficacy Unaffected by Chronic Migraine DurationAugust 15, 2024Headache & Migraine
